The sample-to-answer platform delivered timely and accurate test results during a critical time

[thumbnail]

As COVID-19 began to spread in early 2020, scientists and medical professionals across the world began quickly responding to community needs, shifting priorities to help understand and address the pandemic. At this year’s Association for Molecular Pathology (AMP) annual meeting, we hosted a virtual workshop with one of the scientists working diligently to solve the pandemic puzzle.

Leslie Wolf, PhD, Director of the Infectious Diseases Laboratory (IDL) at the University of Louisville, runs a high-capacity laboratory serving four major health systems in Louisville, Kentucky and southern Indiana. Dr. Wolf and her team knew they needed a reliable testing solution for their community, so they developed an assay to detect SARS-CoV-2 using the ® Laboratory Developed Test for SARS-CoV-2 to Respond to the COVID-19 Pandemic” href=”https://www.youtube.com/watch?v=51ZDa9X1OXY&feature=youtu.be”>here.

For more information about our COVID-19 testing and research solutions, check out our website.

Related Content:

• Luminex Diagnostic COVID-19 Offerings [Webpage]
• A Laboratory’s Perspective: How the University of Louisville Infectious Diseases Lab Leverages Molecular Testing [Blog]
• How Luminex Is Supporting Research Partners’ Pandemic Response [Blog]
• Considerations Regarding RNA Extraction Kits for SARS-CoV-2 Detection[Blog]